Pacific Enviro-Electro Chemistry
To replace large portions of the petrochemical industry with a renewable chemical industry utilizing proprietary electrolysis based chemical processes.
How are we accomplishing this?
We are growing specialty chemical know-how and companies that manufacture and market renewable chemical products (http://peec.biz/).
We are developing several low volume, very high margin products for the F&F (Flavors and Fragrance) and other industries and are in discussions and evaluations with several regional and international chemical sellers to become part of their supply chain.
This technology allows us to replace many commonly used petrochemicals with higher quality lower cost renewable chemicals and we are improving the speed with which we can spin up these new chemical production formulas.
PEEC has developed technology and capability to replace small scale petrochemicals
and at large scale the same technologies will improve the standard of living on a global scale while reducing the carbon footprint.
Dr Rainer Busch is a graduate of the University of Hamburg he completed his “Diploma” thesis on molecular modeling of disaccharides and his Ph.D. thesis on the Monte-Carlo simulations of glycopeptides. In recent years, Rainer has returned his attention to his roots in renewable chemistry, refining existing biodiesel production methods. Rainer has also devised completely new methods with improved yields that creates literally no waste products.
He is currently working on a PEEC to derive hydrocarbons from oils and fats and has been granted patent protection of his IP related to renewable hydrocarbons in Europe and the US.
Kenneth Kron has had a successful career as a technology entrepreneur with a foray into sustainable chemistry in 2001 when he and Rainer founded the first biodiesel production company to headquarter in the San Francisco Bay area. Through most of his career he has utilized his technology, sales and communication skills as a professional services and consulting engineer.
Kenneth studies team building and organizational development with Richard Moon.
Dr. Horst Walther is a graduate of the University of Hamburg, living in Hamburg.
He finished his diploma with a thesis on magneto-chemical behaviour of ultra small Nickel particles and subsequently he completed a Ph.D. thesis on quantum chemical simulations. Since 1994 Horst acts as a business advisor focussing on technical due diligence and the implementation of selected strategic actions in the financial sector.
PEEC est. Market
Compoundtype Retail Volume
F&F compounds $ 100+/kg 100 MT/year
Bio-Pharmaceuticals $1000+/kg 10 MT/year
Pharmaceutical/cosmetic ingredients $ 20+/kg 1000 MT/year
Fine chemicals $ 10+/kg 10K MT/year
Lubricants and waxes $ 5/kg 10K MT/year
White oils and specialty fuels $ 2-8/kg 5000 MT/year
Solvents $ 2-4/kg 5000 MT/year
(non-) petrochemicals $ 2-5/kg 1 MMT/year
Currently, the "organic organics" are being made from extracts from rare and low-yield plant parts, and then possibly split up in high-resolution fractional distillations, isolating thesingle components. Often these are quite diluted, or in mix with a few, or sometimes many others, so the separation process may also be quite costly.
Many of those plant extracts are expensive to begin with, frequently between $100s/kg up to several $1000s. Hence those substances isolated, plus manual (chemical) labour to purify them, or run more synthetic steps
to make derivatives, are even more expensive.
lactones (octalactone, nonalactone, decalactone, dodecalactone and others) several MT/year
small esters, alcohols etc. (too many to list, 50-100, remember the matrix ?) all together several MT/year
exotic lactones jasmolactone, massoialactone, dihydrojasmone lactone, all together several 100 kgs/year
methyltuberate and other similar lactones (sell for $800-$1200/kg today)
PEEC can synthesize many of these “”organics” from inexpensive and plentiful feedstocks.
Of course we can't make anything and everything with this method, however over time we'll gather more and more knowhow, and find other suitable and economical feedstock, and work our way up.
PEEC chemistry requires very low capital costs to build, and the chemistry works at this scale because the product margins are sufficiently high.
Cetyl Acetate (and similar esters used as fragrances) can be produced in a standard esterification procedure with standard glassware, in batches of 10-50 kg. Some of the (natural) feedstocks required (both alcohols and acids) are accessible commercially, others can be derived in-house using our technology. The reaction conditions are very amenable to automation which will keep labor costs low.
Feedstock cost, while variable, carries a low risk as we can utilize various feedstock all of which are currently inexpensive.
PEEC processes are not one size fits all. Through careful analysis each process is designed specifically to convert a specific natural feedstock into a specific high margin product. This makes the process more and more flexible as we gain experience and so nearly eliminates feedstock risk as there are always several possible inputs for each desired output and in fact our processes usually produce more than one desirable product.
This is our primary risk. Most of our processes are achievable with more than one feedstock and our first products are profitable at fairly small quantities. We are mitigating this risk by diversifying into biopharmaceuticals which will broaden our distribution channels.
The PEEC production process relies on a combination of public domain but obscure processes (which if discovered would allow someone to imitate much of our production processes) and patented technologies, which once understood would allow a smart chemist to make an educated guess at the remainder of our technology. We will protect the unpatentable technology as trade secret and have US patent protections on the truly new technologies. International patents should be pursued as cash flow improves.
To date Dr. Busch is the only person who understands or processes end to end. We will mitigate this risk by escrowing critical information and licensing these processes as necessary to the business.
Given the broad portfolio of chemicals we intend to manufacture we do not see any particular set of companies as direct competition. We see our primary competition as the status quo. As we are able to produce higher quality chemicals, renewably at a lower price than is currently available in the market we intend to use our competitors as distribution channels when possible and to focus on opportunities such as biopharma where our advisory board gives us a distinct advantage.
Some of the existing producer we intend to coopt are: